Cancer Weekly articles from September 2000

Cancer Weekly archives from September 2000

Cytokine-Activated Natural Killer Cells Tested in Patients.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Researchers in Germany tested the feasibility of the adoptive transfusion of allogeneic natural killer (NK) cells as therapy for renal cell carcinoma. "Patients with metastasized renal cell carcinoma have...

Study Shows Possible Cancer Link Between Virus and Fiber.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- A possible cancer-causing link has been found between asbestos fibers and a monkey virus that infects some people in the United States. Loyola University Medical Center researchers published the finding in...

Study Examines Participation of Chronically Ill Children.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- A child's understanding of and willingness to participate in a research trial vary depending on the child's age, illness, and previous research experience, according to a recent study by researchers at the...

Safe Method of Sentinal Node Identification Assists in Selective Neck Dissection.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- A new technique has been developed that permits easy and safe identification of sentinal nodes (SNs). The technique may also be beneficial in guiding selective neck dissection, researchers in Italy report....

Molecular Architects Create New Cancer Preventives.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Researchers at The Johns Hopkins University, Maryland, have developed a modified form of vitamin D and determined that it helps delay the onset and reduce the number of skin cancers in lab mice. Unlike...

Growth Inhibitory Fusion Gene Can Target Multiple Tumor Types.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Cell Genesys, Inc. (CEGE), Foster City, California, announced, in collaboration with GPC Biotech AG (GPC), Munich, Germany, that a gene therapy employing a unique, proprietary fusion gene, referred to as...

Human Chromaffin Cell Grafts May Provide Relief When Opioids Fail.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Adrenal medullary allografts may provide relief for patients suffering from chronic, intractable cancer pain when opioids are no longer effective or feasible, researchers writing in Pain report. "A number...

Combined Antibody/Antivascular Therapy Eradicates Tumors in Mouse Model.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Promising results from preclinical studies with an antitumor protocol that combined antibody and antivascular therapy have spurred Phase I clinical trials, researchers in the United Kingdom reported. ...

Protein Inhibits Growth.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- University of Toronto researchers have discovered a protein that suppresses colorectal cancer in mice and human cell cultures. They reported their study in the August 24, 2000 issue of Nature. The...

Vascular Endothelial Growth Factors C and D are Prognostic Factors.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Vascular endothelial growth factors (VEGF) C and D not only influence pathogenesis in patients with colorectal cancer, but can be significantly correlated with survival, according to a study presented at the...

Test Detects and Monitors Peptic Ulcer and Gastric Cancer.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Biomerica, Inc. (BMRA), Newport Beach, California, introduced its Pepgen test as an aid to detect and monitor the presence of peptic ulcers and gastric carcinoma (stomach cancer). The Pepgen test...

Licensing Agreement Announced.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- BioChem Pharma Inc. (BCHE; BCH) announced the signing of a research and licensing agreement with Adherex Technologies Inc., Laval, Quebec, Canada, covering a series of anticancer compounds based on cell...

Discovery in Proprietary DNA Delivery System Announced.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Supratek Pharma, Montreal, Quebec, Canada, announced at the American Chemical Society Annual Conference (ACS) that SP1017, its non-viral gene delivery system, significantly increases gene expression in muscle,...

Anti-Angiogenic Therapy Can Stop Tumor Cell Infiltration.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Anti-angiogenesis agents will stop the invasion of glioma tumors in tumor-transplanted nude mice, researchers in Germany report. P. Vajkoczy and colleagues, University of Heidelberg in Mannheim, Germany,...

Long-Term Follow-up Study Examines Prospects for Hepatitis C Patients.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Unfortunately, being infected with the hepatitis C virus (HCV) places an individual at a higher risk for acquiring hepatocellular carcinoma. According to a long-term follow up study conducted in Japan, some...

Antibody Therapy Highly Potent in Murine Model.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Researchers in Germany have created an antibody-based immunotherapy that produces promising results in animal cancer models. "The use of anti-CD3xantitumor bispecific Abs [antibodies] is an attractive and...

Adenovirus-Mediated FHIT Gene Transfer Suppresses Growth in vivo.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Adenovirus-mediated transfer of the human fragile histidine triad (FHIT) gene reduced tumor growth in an animal model, researchers in Japan reported. "FHIT gene is one of the novel tumor suppressor genes...

Immune System Stimulant Enters Clinical Trials.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- LifeTime Pharmaceuticals (LifeTime), College Park, Maryland, announced the first U.S. clinical trials for Beta LT, a drug designed to stimulate the immune system. Future indications may include hepatitis C...

Adoptive Immunotherapy Successful Against PTLD.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Researchers in the United Kingdom have successfully used allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) to treat post-transplant lymphoproliferative disease (PTLD). "Autologous...

Heat-Induced Gene Expression Sensitizes Cancer Cells to Hyperthermia.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Using gene transfer of heat shock protein 70 promoter, researchers in the United States were able to sensitize melanoma cells to hyperthermia. "One of the main advantages of gene therapy over traditional...

HER-2/neu Oncoprotein is Expressed in Renal Cell Carcinomas.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Previous studies have demonstrated that the HER-2/neu oncoprotein is associated with ovarian and breast cancer pathology. A new study conducted at the University of Mainz has shown that various types of renal...

Immunotoxin Targets Mesothelin, Effective in Animal Models.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Immunotoxins targeting mesothelin may have therapeutic potential against ovarian cancer and malignant mesotheliomas. Researchers in the United States evaluated the anti-tumor activity of the immunotoxin...

Fresh vs. Thawed: Both Tissue Types Display Angiogenesis in Nude Mice.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- For some time now, medical researchers have been studying the efficacy of ovarian transplants. These types of transplants could be beneficial to women who suffer from certain types of infertility. ...

p53 and p16 Gene Transfer Causes Tumor Regression in Mice.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- Adenovirus-mediated transfer of the p53 and p16(INK4a) genes resulted in tumor regression in an animal model, researchers in the United Kingdom and the United States reported. "Pancreatic cancer has a very...

Patent Issued for Monoclonal Antibodies Binding to Prostate-Specific Membrane Antigen.
September 5, 2000... 2000 SEP 5 - (NewsRx.com) -- BZL Biologics Inc., New York, New York, announced that Cornell University in New York was issued U.S. Patent No. 6,107,090 titled "Treatment and Diagnosis of Prostate Cancer. BZL holds the exclusive...

First Potential 'Universal' Vaccine Shows Promise in Lab.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Results from preliminary laboratory studies provide the first functional evidence that developing a "universal" cancer vaccine might be possible, researchers from Duke University Medical Center and Geron...

Dual Drug Treatment Prevents Formation of Colon Tumors in Mice.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- By combining an aspirin-like compound with a drug that inhibits epidermal growth factor activity, scientists have nearly eliminated pre-cancerous colon polyps in mice that are susceptible to developing colon...

Publication Bias Causes Overestimate of Associated Cancer Risk.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Estimates of the risk of esophageal cancer from a condition known as Barrett's esophagus apparently are exaggerated by the tendency of medical journals to favor articles with more dramatic results, according...

Stereotactic Radiosurgery Improves Survival With or Without Radiation Therapy.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- A study published in the September 1, 2000, issue of Cancer found that stereotactic radiosurgery with or without whole brain radiation therapy (WBRT) had a positive impact on the survival of patients with a...

COX-2 Inhibitors Suppress Prostate Cancer Spread.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- A study by researchers at The George Washington University Medical Center, Washington, DC, has shown that common anti-inflammatory drugs, such as ibuprophen and the new COX-2 inhibitors, suppressed the...

Plant Compound Blocks Action of Cancer Genes.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- A plant compound that produces severe neural defects in developing embryos can block the action of mutated genes that produce basal cell skin carcinomas, the most common form of human cancer. According to...

Cancer Screening Can Confuse Statistics.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Overdiagnosis can wreak havoc with cancer survival statistics and can be more harmful than helpful, a Dartmouth Medical School physician cautions. William Black, MD, professor of radiology and of...

Immunomodulating Effects of Surgery Studied.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Factors such as extension of trauma, age, type of anesthesia, and type of intensive care intervention were not directly related to specific immunomodulating effects of surgical intervention in head and neck...

Binary/Ternary Combinations of VK3 and Other Anticancer Agents are Effective Inhibitors of Cancer Cell Growth.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in Taiwan have been searching for an effective combination of chemotherapies for the treatment of nasopharyngeal carcinoma (NPC), a common form of cancer in Taiwan. Previous studies by W.C....

Prior Head and Neck Irradiation Not a Deterrent.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- According to researchers in Australia, adolescents and young adults who have had prior irradiation for childhood malignancy are at increased risk of malignancy. Consequently, there has been a rise in the...

Highly Active Antiretroviral Therapy Active Against Kaposi's Sarcoma.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Highly active antiretroviral therapy (HAART) is useful against Kaposi's sarcoma (KS), researchers in Italy reported. "HAART has significantly reduced the KS incidence among HIV infected patients,"...

Looking for Estrogen Receptor Subtypes Can Maximize Treatment Options.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- One of the major steps in determining a course of treatment for breast cancer patients is to determine whether or not their tumors are estrogen receptive. According to a study presented at the British...

Prior Treatments and Metastasis Affect Blood Stem Cell Harvests.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Prior treatments and bone marrow (BM) metastasis in breast cancer patients affect the progenitor cell content of blood stem cell (BSC) harvests, researchers in Turkey and the United States reported. Ahmet...

Chimeric Anti-Ganglioside GD3 Antibody KM871 Has Therapeutic Potential.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in Japan have found that the chimeric anti-ganglioside GD3 antibody, KM871, has anticancer therapeutic potential. "KM871 is a chimeric antibody recognizing ganglioside GD3, which is one of the...

Phase I Clinical Trial Data Reported.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Data from a Phase I clinical trial of the therapeutic cancer vaccine based on B7-1 (H5.030CMVHB7) were reported at the 36th Annual Meeting of the American Society of Clinical Oncology, held in New Orleans,...

Discovery Process Detects Presence of Cancer-Specific Proteins.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Matritech Inc. (NMPS), Newton, Massachusetts, announced the completion of preliminary testing which confirmed the presence of colon cancer-specific proteins in the blood of patients with this disease. In...

Meta-Analysis Indicates Vaccine Extends Recurrence-Free Survival in Stage II Disease.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Intracel Corp., Rockville, Maryland, reported the findings of a meta-analysis of three clinical trials that demonstrated its autologous tumor cell vaccine, OncoVAX, significantly improves the recurrence-free...

Symposium Will Highlight New Leads in Cancer Therapeutics.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Roswell Park Cancer Institute (RPCI) will host a symposium titled, "Molecular Sites of Intervention for Cancer Therapeutics," October 12-13, 2000 in Buffalo, New York. The symposium will describe and...

Methimazole Increases Impact of P450 Suicide Gene Therapy.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Methimazole (MMI) increases the therapeutic index of p450 prodrug activation-based cancer gene therapy, recent study findings show. "The effect of the antithyroid drug MMI on cytochrome P450/P450...

Radiofrequency Ablation Offers New Hope.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Mayo Clinic physicians in Rochester, Minnesota, now offer a successful treatment for liver cancer patients who previously had little hope of survival. The procedure is called radiofrequency (RF) ablation,...

p53 Gene Therapy & Radiation: Clinical Trial Results Promising.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Results from a Phase II clinical trial of adenovirus-mediated p53 gene therapy in conjunction with radiation in patients with localized non-small cell lung cancer (NSCLC) appear very promising. "We...

Investigational Treatment Shows Promise in Clinical Trials.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Increased emphasis has been placed on potential treatments for the late stages of melanoma. "Although it's best to catch skin cancer before it progresses, most people aren't diagnosed until their disease...

Novogen Anti-Cancer Drug Trials Advance.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Novogen Limited, (NVGN; NRT) announced that its anti-cancer drug, NV-06, has advanced to the next stage of clinical trialing. The company has received approval for NV-06 to enter a Phase I-II trial at a...

Pilot Trial Combines Chemotherapy/Rituximab for HIV Associated Disease.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in Italy and the United States tested cyclophosphamide, doxorubicin, and etoposide (CDE) combined with the anti-CD20 monoclonal antibody (MAb) rituximab in patients with HIV associated...

Concurrent Daniplestim and G-CSF is Safe and Efficacious in Cancer Patients.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in the United States have determined that the concurrent administration of daniplestim with granulocyte colony-stimulating factor (G-CSF) is safe and efficacious for the mobilization of peripheral...

Suicide Gene Therapy Enhanced by Pituitary Specific Replication-Competent Adenovirus.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in the United States found that herpes simplex virus (HSV)-thymidine kinase (TK)/ganciclovir (GCV) suicide gene therapy for pituitary tumors was enhanced by use of a pituitary specific...

C-fms-like Tyrosine Kinase Receptors Regress with Disease Progression.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- An in-depth study of different classifications of prostate tumors has shown that some receptors for vascular endothelial growth factor (VEGF), termed c-fms-like kinase (Flt-1) receptors, tend to regress with...

Naked DNA and Adenoviral Immunization Evaluated in Two-Year Study.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Researchers in the United States and Bulgaria have conducted a two-year trial of immunotherapy for prostate cancer. "We have developed a method for inducing sustained autoimmunity against the human...

Vascular Endothelial Growth Factor Subtypes May Vary by Genes or Geography.
September 12, 2000... 2000 SEP 12 - (NewsRx.com) -- Results of a collaborative research effort conducted by medical investigators at several research institutions in the United States indicate that there is a possibility that vascular endothelial growth factor...

Radiotherapy Technique Spares Glands in Oropharynx and Larynx, Increases Dose Homogeneity.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- A new three-dimensional conformal radiotherapy technique may help spare patients with midline head and neck tumors the common, uncomfortable side effect of dry mouth. The procedure, developed by...

Suramin Toxicity Reduced by Alternative Mode Delivery.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Suramin, a drug that is effective against lipid growth factors, is not often used in cancer treatment regimens because it causes systemic toxicity. One way to get around that toxicity, according to...

Newly-Discovered Drug Prolongs Survival in Some Patients with Rare Cancer.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- New research published recently in the journal Thyroid shows that paclitaxel (Taxol(R)) has significant clinical activity against anaplastic thyroid carcinoma (ATC). The research study was led by Kenneth...

Study: Terminally Ill Cancer Patients Favor Legalization of Euthanasia and Physician-Assisted Suicide.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Patients with advanced stage cancer favor policies that allow euthanasia and physician-assisted suicide if pain and physical symptoms become intolerable, according to an article in the September 11, 2000,...

Researchers Say "Hawkeye" Scanner Big Stride in Cancer Fight.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- A new scanner - nicknamed "Hawkeye" because of its diagnostic power - could significantly improve the diagnosis and treatment of cancer, say the Vanderbilt University researchers who helped develop it. ...

Method Developed to Identify Patients at High Risk for Relapse.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Researchers from the Parker Hughes Institute in St. Paul, Minnesota, reported findings that demonstrate the quality of remission for acute lymphoblastic leukemia (ALL) patients after first relapse is lower...

Measuring Telomerase Activity May Have Prognostic and Diagnostic Applications.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Progression of oral cancers, as well as identification of malignant salivary gland tumors, may be determined by measuring levels of telomerase activity in biopsy specimens, researchers suggest. J. Liao...

Lung-Sparing Technique Improves Quality of Life without Sacrificing Cure.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- University of Pennsylvania surgeons perform - and teach - a once-rare procedure: saving clear portions of cancer-ridden lungs when even a main pulmonary artery is involved in malignancy Procedure has...

FDA Clears Applied Imaging System to Detect Cancer Cells.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Applied Imaging Corp. (AICX), Santa Clara, California, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its MDS system for detecting micrometastatic...

Long-Term Tamoxifen Users Have Worse Prognosis of Endometrial Cancers.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- A less favorable prognosis of endometrial cancer after long-term tamoxifen use, described in the September 9, 2000, issue of The Lancet, suggests the need to question widespread use of the drug as a preventive...

Magnetic Bead Immunoselection Process Removes Ewing's Sarcoma Cells.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Researchers in the United States have developed a magnetic bead immunoselection process that purges Ewing's sarcoma cells from autologous blood. "Ewing's sarcoma is a childhood tumor characterized by a...

Adenovirus is Aggressive Against Tumor Xenografts.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Collaborating researchers in France and the United States showed that ONYX-015, an E1B-deleted adenovirus, has excellent antitumor activity against human malignant glial brain tumor xenografts. "Malignant...

Cyanide Shows Promise in Treatment.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Researchers at London's Imperial College, funded by U.K.-based cancer company Antisoma plc, have harnessed a cyanide-generating system, used by plants as a natural defense mechanism to fend off insects, as a...

Fungal Metabolite Cytochalasin E Exhibits Anti-Tumor Properties in Mouse Model.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Harvard University researchers say that a metabolite derived from a species of Aspergillus fungus has the potential for use as an anti-tumor agent. The metabolite is called cytochalasin E. Cytochalasins...

Mycobacterium tuberculosis Ag38 Gene Cooperates with Interleukin 12 Against Tumors.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- A novel anticancer immunotherapy approach combines bacteria and cytokines in a vaccine vehicle. "An approach to stimulating an immune response against tumors is to transduce tumor cells with bacterial...

Results of p53 Gene Therapy Trial in Recurrent Cancer are Encouraging.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Preliminary results from a Phase I clinical trial of p53 gene therapy for recurrent glioma are encouraging, researchers in the United States report. "Conventional treatments of human gliomas have achieved...

Radioimmunotherapy with 131-I-3F8 Monoclonal Antibody Reaches Phase I Trial.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Researchers in the United States presented promising preliminary results from a Phase I clinical trial of a radioimmunotherapy (RIT) procedure against GD2-positive leptomeningeal (LM) cancers using the...

Adoptive Immunotherapy Reported Safe and Feasible.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Adoptive immunotherapy using anti-HER2/neu + anti-Fc gamma RI bispecific antibody in patients with ovarian cancer was safe and feasible, researchers in France and Belgium reported at a recent conference. ...

Phase I Trial Targets Monoclonal Antibody to Prostate-Specific Membrane Antigen.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Results from a Phase I clinical trial of a monoclonal antibody (MAb) targeting the extracellular domain of prostate specific membrane antigen (PSMAext) in patients with hormone-independent prostate cancer are...

Bacterial Protein Shows Promise for Cancer Vaccine.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- A non-toxic form of a bacterial protein known as Shiga B-subunit, together with tumor-associated molecules, can stimulate the immune system of mice to attack cancer cells without the need for secondary...

Antisense Vascular Endothelial Growth Factor Therapy is Promising.
September 19, 2000... 2000 SEP 19 - (NewsRx.com) -- Antisense vascular endothelial growth factor (VEGF) transfection downregulated VEGF secretion in human squamous cell carcinoma of the head and neck (SCCHN), according a study by researchers in the United...

Photodynamic Therapy Effective for Inoperable Tumors.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- Photodynamic therapy (PDT) is an effective alternative palliative therapy for patients suffering from advanced cancer of the esophagus, according to researchers writing in the journal Surgical Endoscopy -...

Chemotherapy/Radiotherapy Combination Effective for Short-Term Recurrent Tumor Control.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- Retreatment of previously irradiated head and neck carcinomas with a combination of chemotherapy and an additional course of radiotherapy appears to be an effective method for short-term tumor control. U....

Researchers Work to Combat Dangerous Fungal Compounds.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- There's a fungus among us, as the saying goes, and its one researchers are working hard to eradicate. Recently, plant health scientists gathered in New Orleans, Louisiana, for their annual meeting,...

Routine Follow-Up Improves Prospects for Long-Term Survival.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- Patients who have regular follow-up visits with medical professionals after a diagnosis of hepatocellular carcinoma have the best chance for long-term survival, say researchers in Japan. Medical...

Weekly Paclitaxel Plus Carboplatin is Safe, Effective in Patients with Advanced Disease.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- New data show that patients with advanced lung cancer may have a safer chemotherapy treatment option. The use of Taxol (paclitaxel) plus Paraplatin (carboplatin), administered in a novel weekly regimen,...

Amyloidosis May be Indicative of Malignancy.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- The presence of amyloid deposits in the nasopharynx may be associated with malignancy in that area. "The association of amyloidosis and tumors is well known, but only rarely has it been found in the...

Combination of Chemotherapy and Radiation Therapy is Effective for Children.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- A regimen combining chemotherapy and radiation therapy is effective for pediatric nasopharyngeal cancer patients, oncologists report. "A high cure rate may be attained for locally advanced,...

Lymphoscintigraphy is an Effective Screening Method.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- Lymphoscintigraphy, a radiographic screening technique, is an effective method for diagnosing malignant swelling of the lymph nodes, according to researchers writing in the journal Dentomaxillofacial...

Regression of Advanced Kidney Cancer Seen with Allogeneic Stem Cell Transplantation.
September 26, 2000... 2000 SEP 26 - (NewsRx.com) -- Researchers at the U.S. National Institutes of Health (NIH) report that advanced kidney cancer, a disease notoriously resistant to therapy and usually fatal, can be completely or partially reversed in some...